Home » Stocks » Zynex

Zynex, Inc. (ZYXI)

Stock Price: $17.04 USD 0.22 (1.31%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $17.30 +0.26 (1.53%) Aug 7, 7:54 PM

Stock Price Chart

Key Info

Market Cap 591.38M
Revenue (ttm) 60.47M
Net Income (ttm) 10.93M
Shares Out 34.71M
EPS (ttm) 0.32
PE Ratio 53.25
Forward PE 58.48
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $17.04
Previous Close $16.82
Change ($) 0.22
Change (%) 1.31%
Day's Open 16.87
Day's Range 16.69 - 17.43
Day's Volume 681,467
52-Week Range 7.51 - 29.73

More Stats

Market Cap 591.38M
Enterprise Value 579.72M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 34.71M
Float 19.52M
EPS (basic) 0.33
EPS (diluted) 0.32
FCF / Share 0.20
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.88%
FCF Yield 1.11%
Payout Ratio n/a
Shares Short 5.17M
Short Ratio 4.08
Short % of Float 33.07%
Beta 0.93
PE Ratio 53.25
Forward PE 58.48
P/FCF Ratio 90.30
PS Ratio 9.78
PB Ratio 23.25
Revenue 60.47M
Operating Income 12.77M
Net Income 10.93M
Free Cash Flow 6.55M
Net Cash 11.67M
Net Cash / Share 0.34
Gross Margin 60.82%
Operating Margin 21.12%
Profit Margin 18.10%
FCF Margin 10.83%
ROA 27.24%
ROE 53.31%
ROIC 80.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 3
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$27.35*
(60.50% upside)
Low
22.5
Current: $17.04
High
31.3
Target: 27.35
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue45.4731.9223.4313.3111.6411.1221.6847.1539.6828.49
Revenue Growth42.47%36.21%76.01%14.36%4.71%-48.73%-54.01%18.84%39.29%-
Gross Profit36.6625.8818.619.806.703.5113.5438.3832.3123.28
Operating Income11.0710.378.940.64-2.48-5.70-7.6010.228.635.96
Net Income9.499.557.370.07-2.91-6.20-7.301.551.560.35
Shares Outstanding32.4432.5032.1631.2731.2731.2131.1531.0630.7530.55
Earnings Per Share0.280.280.22--0.09-0.20-0.230.050.050.01
EPS Growth0%27.27%-----0%400%-
Dividend Per Share-0.07---0.15----
Operating Cash Flow6.309.418.261.770.340.96-0.38-0.88-0.36-0.67
Capital Expenditures-0.16-1.08-0.09-0.230.01-0.27-0.64-0.76-1.27-0.67
Free Cash Flow6.148.338.171.540.350.69-1.03-1.64-1.63-1.34
Cash & Equivalents14.3710.445.940.300.060.070.720.990.960.78
Total Debt4.683.660.353.034.334.836.066.163.681.69
Net Cash / Debt9.696.785.58-2.72-4.26-4.77-5.34-5.17-2.72-0.91
Assets28.2819.258.934.093.707.1117.2225.9421.7915.70
Liabilities8.629.964.037.897.778.3812.3713.8811.657.52
Book Value19.749.384.99-3.71-3.98-1.204.8812.0510.148.18
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Zynex, Inc.
Country United States
Employees 283
CEO Thomas Sandgaard

Stock Information

Ticker Symbol ZYXI
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: ZYXI

Description

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.